Jazz Pharmaceuticals Plc (JAZZ)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	16.47% 1,045.71	897.84	1,088.17	1,054.97	1,023.83
Operating Expenses	81.61% 1,732.10	953.73	897.40	794.76	824.38
Benefits Costs and Expenses	76.77% 1,781.27	1,007.65	954.95	854.16	885.90
Costs And Expenses	81.61% 1,732.10	953.73	897.40	794.76	824.38
Operating Income/Loss	1,128% -686.39	-55.89	190.77	260.21	199.44
Income/Loss Before Equity Method Investments	569.84% -735.55	-109.81	133.22	200.81	137.93
Income/Loss From Equity Method Investments	84.13% -0.086	-0.542	-0.016	-0.285	-0.012
Income/Loss From Continuing Operations Before Tax	569.84% -735.55	-109.81	133.22	200.81	137.93
Income Tax Expense/Benefit, Deferred	51.53% -66.42	-43.83	-2.355	-64.40	-75.18
Income Tax Expense/Benefit	3.60% -17.17	-17.81	-57.91	-14.53	-30.65
Income/Loss From Continuing Operations After Tax	676.29% -718.38	-92.54	191.13	215.34	168.57
Net Income/Loss	676.38% -718.47	-92.54	191.12	215.06	168.57
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.35% 61.19	60.98	-0.437	61.41	62.88
Diluted Average Shares	0.35% 61.19	60.98	-1.504	63.17	69.62
Basic Earnings Per Share	672.37% -11.74	-1.52	3.13	3.50	2.68
Diluted Earnings Per Share	672.37% -11.74	-1.52	3.02	3.42	2.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%